SCHEDULE 13G

Company

IO Biotech, Inc.

Filed

November 12, 2021

Accession Number

0001213900-21-058703

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →